Cargando…
Evaluation of mortality risk after COVID-19 vaccination, Utah 2021
INTRODUCTION: In order to evaluate trends in death after COVID-19 vaccination we analyzed the timing of death relative to vaccination date and the causes of death in vaccinated Utahns in 2021. METHODS: We matched people in the Utah immunization registry with documented COVID-19 vaccinations between...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073592/ https://www.ncbi.nlm.nih.gov/pubmed/37037710 http://dx.doi.org/10.1016/j.vaccine.2023.03.072 |
_version_ | 1785019605352185856 |
---|---|
author | Payne, Jessica R. Bose, Srimoyee Kubiak, Rachel W. Nolen, Leisha D. |
author_facet | Payne, Jessica R. Bose, Srimoyee Kubiak, Rachel W. Nolen, Leisha D. |
author_sort | Payne, Jessica R. |
collection | PubMed |
description | INTRODUCTION: In order to evaluate trends in death after COVID-19 vaccination we analyzed the timing of death relative to vaccination date and the causes of death in vaccinated Utahns in 2021. METHODS: We matched people in the Utah immunization registry with documented COVID-19 vaccinations between December 18, 2020 and December 31, 2021 to Utah’s 2021 vital statistics death records. Vaccinated people were categorized as having one, two, or ≥ three COVID-19 vaccine doses in a time-updated metric. We examined crude mortality rates by dosing groups in two-week intervals for all deaths, and by COVID-19 versus non-COVID-19 causes, within the 44 weeks following receipt of the most recent vaccine. RESULTS: We identified 2,072,908 individuals who received at least one dose of COVID-19 vaccine of whom 10,997 died in 2021. Only 17.5 % of the total vaccinated population was age 65+, while 80.9 % of those who died were over 65. In the four weeks following the first or second vaccination, all-cause mortality was low and then stabilized for the remainder of the evaluation period at a bi-weekly average of 33.0 and 39.0 deaths/100,000 people for one and two doses, respectively. Typical seasonal variation in death was observed among those with two doses. Small sample size precluded analysis of those with ≥ three doses, but trends were similar. CONCLUSIONS: Mortality rates in the 44 weeks following the COVID-19 vaccination did not show trends suggesting an increase in mortality related to COVID-19 vaccination, reinforcing the safety of COVID-19 vaccines. This represents an accessible approach for local evaluation. |
format | Online Article Text |
id | pubmed-10073592 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100735922023-04-05 Evaluation of mortality risk after COVID-19 vaccination, Utah 2021 Payne, Jessica R. Bose, Srimoyee Kubiak, Rachel W. Nolen, Leisha D. Vaccine Article INTRODUCTION: In order to evaluate trends in death after COVID-19 vaccination we analyzed the timing of death relative to vaccination date and the causes of death in vaccinated Utahns in 2021. METHODS: We matched people in the Utah immunization registry with documented COVID-19 vaccinations between December 18, 2020 and December 31, 2021 to Utah’s 2021 vital statistics death records. Vaccinated people were categorized as having one, two, or ≥ three COVID-19 vaccine doses in a time-updated metric. We examined crude mortality rates by dosing groups in two-week intervals for all deaths, and by COVID-19 versus non-COVID-19 causes, within the 44 weeks following receipt of the most recent vaccine. RESULTS: We identified 2,072,908 individuals who received at least one dose of COVID-19 vaccine of whom 10,997 died in 2021. Only 17.5 % of the total vaccinated population was age 65+, while 80.9 % of those who died were over 65. In the four weeks following the first or second vaccination, all-cause mortality was low and then stabilized for the remainder of the evaluation period at a bi-weekly average of 33.0 and 39.0 deaths/100,000 people for one and two doses, respectively. Typical seasonal variation in death was observed among those with two doses. Small sample size precluded analysis of those with ≥ three doses, but trends were similar. CONCLUSIONS: Mortality rates in the 44 weeks following the COVID-19 vaccination did not show trends suggesting an increase in mortality related to COVID-19 vaccination, reinforcing the safety of COVID-19 vaccines. This represents an accessible approach for local evaluation. Elsevier Ltd. 2023-05-02 2023-04-05 /pmc/articles/PMC10073592/ /pubmed/37037710 http://dx.doi.org/10.1016/j.vaccine.2023.03.072 Text en © 2023 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Payne, Jessica R. Bose, Srimoyee Kubiak, Rachel W. Nolen, Leisha D. Evaluation of mortality risk after COVID-19 vaccination, Utah 2021 |
title | Evaluation of mortality risk after COVID-19 vaccination, Utah 2021 |
title_full | Evaluation of mortality risk after COVID-19 vaccination, Utah 2021 |
title_fullStr | Evaluation of mortality risk after COVID-19 vaccination, Utah 2021 |
title_full_unstemmed | Evaluation of mortality risk after COVID-19 vaccination, Utah 2021 |
title_short | Evaluation of mortality risk after COVID-19 vaccination, Utah 2021 |
title_sort | evaluation of mortality risk after covid-19 vaccination, utah 2021 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073592/ https://www.ncbi.nlm.nih.gov/pubmed/37037710 http://dx.doi.org/10.1016/j.vaccine.2023.03.072 |
work_keys_str_mv | AT paynejessicar evaluationofmortalityriskaftercovid19vaccinationutah2021 AT bosesrimoyee evaluationofmortalityriskaftercovid19vaccinationutah2021 AT kubiakrachelw evaluationofmortalityriskaftercovid19vaccinationutah2021 AT nolenleishad evaluationofmortalityriskaftercovid19vaccinationutah2021 |